XML 19 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Dec. 28, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 59 $ 269
Accounts receivable, less allowances of $24 and $18 1,957 1,854
Vendor receivables, less allowances of $7 and $5 167 156
Inventories—net 1,626 1,600
Prepaid expenses 146 138
Assets held for sale 8 0
Other current assets 11 14
Total current assets 3,974 4,031
Property and equipment—net 2,398 2,280
Goodwill 5,766 5,697
Other intangibles—net 836 803
Other assets 429 376
Noncurrent assets held for sale 33 0
Total assets 13,436 13,187
Current liabilities:    
Cash overdraft liability 216 220
Accounts payable 2,231 2,051
Accrued expenses and other current liabilities 732 731
Current portion of long-term debt 109 110
Liabilities held for sale 8 0
Total current liabilities 3,296 3,112
Long-term debt 4,819 4,564
Deferred tax liabilities 335 293
Other long-term liabilities 447 469
Noncurrent liabilities held for sale 11 0
Total liabilities 8,908 8,438
Commitments and contingencies (Note 21)
Shareholders' equity:    
Common stock, $0.01 par value—600 shares authorized; 254.7 issued and 230.5 outstanding as of December 28, 2024, and 252.9 issued and 245.1 outstanding as of December 30, 2023, respectively 3 3
Additional paid-in capital 3,748 3,663
Retained earnings 2,003 1,509
Accumulated other comprehensive income (loss) 43 (115)
Treasury Stock, 24.2 and 7.8 shares, respectively (1,269) (311)
Total shareholders’ equity 4,528 4,749
Total liabilities and shareholders’ equity $ 13,436 $ 13,187
Common stock, shares outstanding (in shares) 230.5 245.1